feed,title,long_url,short_url
🔐MarketWatch,Dow Jones Newswires: AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU,http://www.marketwatch.com/news/story.asp?guid=%7B20C0C4D5-7425-4434-F126-41E9DFFB23FF%7D&siteid=rss&rss=1,https://da.gd/q3Z5B
